The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease
Open accessAbstract
BACKGROUND AND AIMS: The intestinal microbiota play a pivotal role in the inflammation associated with Crohn's disease through their interaction with the mucosal immune system. Some bifidobacteria species are immunoregulatory and induce increased dendritic cell interleukin 10 (IL-10) release in vitro. Fructo-oligosaccharides (FOS) increase faecal and mucosal bifidobacteria in healthy volunteers. The aim of this study was to assess the effect of FOS administration on disease activity, bifidobacteria concentrations, and mucosal dendritic cell function in patients with moderately active Crohn's disease. PATIENTS AND METHODS: Ten patients with active ileocolonic Crohn's disease received 15 g of FOS for three weeks. Disease activity was measured using the Harvey Bradshaw index. Faecal and mucosal bifidobacteria were quantified by fluorescence in situ hybridisation, and mucosal dendritic cell IL-10 and Toll-like receptor (TLR) expression were assessed by flow cytometry of dissociated rectal biopsies. RESULTS: FOS induced a significant reduction in the Harvey Bradshaw index from 9.8 (SD 3.1) to 6.9 (3.4) (p<0.01). There was a significant increase in faecal bifidobacteria concentration from 8.8 (0.9) log(10) to 9.4 (0.9) log(10) cells/g dry faeces (p<0.001). The percentage of IL-10 positive dendritic cells increased from 30 (12)% to 53 (10)% (p=0.06). Finally, the percentage of dendritic cells expressing TLR2 and TLR4 increased from 1.7 (1.7)% to 36.8 (15.9)% (p=0.08) and from 3.6 (3.6)% to 75.4 (3.4)% (p<0.001), respectively. CONCLUSIONS: FOS supplementation increases faecal bifidobacteria concentrations and modifies mucosal dendritic cell function. This novel therapeutic strategy appears to decrease Crohn's disease activity in a small open label trial and therefore warrants further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an open label trial of fructo-oligosaccharide in CD showed promise,79”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [79]
In the citing paper
“Additionally, prebiotic use has been shown to improve mucosal dendritic cell function associated with TLR2 activity [62], and increase the expression of glucagon-like peptide 2, associated with GI barrier regulation [59].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Amann, R., Binder, B. J., Olson, R. J., Chisholm, S. W., Devereux, R., & Stahl, D. A. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.6.1919-1925.1990 · Cited by 4,049
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,974
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
Gibson, G. R., Beatty, E. R., Wang, X., & Cummings, J. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90192-2 · Cited by 1,529
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Mucosal flora in inflammatory bowel disease
Swidsinski, A. V., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V. A., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,344
Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., & SCHLEIFER, K. H. (1996) · Microbiology · doi:10.1099/13500872-142-5-1097 · Cited by 1,176
Research works printed but not linked: 1
- Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4 beta7 integrin. Eur J Immunol 2002;32:1445-54.
Cited by
Sorted by citations
Items 401–469 of 469
Lactic Acid Bacteria and Plant Fibers
Bengmark, S. (2009) · CRC Press eBooks · doi:10.1201/9781420062151.pt2 · Cited by 1
Immunobiology of Human Dendritic Cells in Inflammatory Bowel Disease
Baumgart, D. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-33703-6_7 · Cited by 1
New nutritional approach to inflammatory bowel disease: the nutraceuticals
Taus, M., Busni, D., Petrelli, M., & Nicolai, A. (2009) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-008-0022-3 · Cited by 1
Peña‐Cearra, A., Fullaondo, A., & Abecia, L. (2022) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.23519
Probiotics, Prebiotics, and Antibiotics in Medical Management of Inflammatory Bowel Disease
Gionchetti, P., & Rizzello, F. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0998-4_43 · Cited by 1
Effects of Probiotics and Prebiotic Milk Oligosaccharides in Murine Models of Food Allergy
Castillo, L. (2015) · MacSphere (McMaster University) · doi:10.71548/12392 · Cited by 1
Healey, G. R., Tsai, K., Lisko, D. J., Cook, L. E., Vallance, B. A., & Jacobson, K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.02.429403 · Cited by 1
Röytiö, H., Tiihonen, K., & Ouwehand, A. C. (2012) · Wiley eBooks · doi:10.1002/9781118373941.ch3 · Cited by 1
Kafsi, H. E. (2014) · theses.fr (ABES) · doi:10.70675/c3ef71e9z2564z4f3fza520z4e48023240b0 · Cited by 1
Discovery and characterization of glycoside-transporters from uncultured bacteria
Wang, Z. (2020) · theses.fr (ABES) · doi:10.70675/718b82b9z9fd2z41c1za898zfbaf9e9c6c8f · Cited by 1
Prebiotics and Synbiotics: Panacea or Placebo
Lindsay, J. O. (2011) · doi:10.1002/9781444342574.ch8
Self-citationMatricon, J. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
The role of the gut microbiota in inflammatory diseases of childhood
Barclay, A. R. (2010) · Enlighten: Theses (The University of Glasgow)
Investigación de propiedades prebióticas de alimentos o componentes alimenticios
Sarmiento-Rubiano, L. A. (2008) · Orinoquia · doi:10.22579/20112629.118
Gentherapie zur Behandlung der akuten inflammatorischen Immunantwort
Tschöke, S. K., & Oberholzer, A. (2007) · Der Orthopäde · doi:10.1007/s00132-007-1060-0
12th World Congress on Clinical Nutrition: Nutritional factors in health and disease
Lacroix, F. C. (2008) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2007.00676.x
Understanding the rationale and use of probiotics in the treatment of IBD
Burch, J. (2009) · Gastrointestinal Nursing · doi:10.12968/gasn.2009.7.3.41779
Rôle du microbiote dans les maladies inflammatoires de l’intestin
Chermesh, I., & Shamir, R. (2009) · Annales Nestlé (Ed française) · doi:10.1159/000222313
Fructo-Oligosaccharides as Therapeutics for Active Crohnʼs Disease: Adequate Power and No Effect
Valcheva, R. S., & Dieleman, L. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21760
Nutrition au cours des maladies inflammatoires de ľintestin
Nion–Larmurier, I., & Cosnes, J. (2007) · Springer eBooks · doi:10.1007/978-2-287-33475-7_74
Immunobiology of Dendritic Cells in Inflammatory Bowel Disease
Baumgart, D. C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0998-4_10
Effects of Brassica on the human gut microbiota
Kellingray, L. (2015) · UEA Digital Repository (University of East Anglia)
Russian Federation (2013) · CyberLeninK (CyberLeninka)
TEMA 9. ANTIBIÓTICOS, PROBIÓTICOS Y PREBIÓTICOS EN LA ENFERMEDAD INFLAMATORIA INTESTINAL
Aguilar, F. C., Ramos, C. R., & Gallego, M. M. (2008)
Probiotics and Prebiotics in Crohn’s Disease
Mikolaitis, S. L., Chakradeo, P. S., & Mutlu, E. (2013) · CRC Press eBooks · doi:10.1201/b15561-21
Application of Functional Dairy Products from IBS to IBD
Karakan, T. (2009) · CRC Press eBooks · doi:10.1201/9781420082081-c13
Clarke, S. T. (2016) · e-scholar@UOIT (University of Ontario Institute of Technology)
Use of probiotics and prebiotics in inflammatory bowel disease
Verma, S., Valcheva, R. S., Bakkari, S., & Dieleman, L. A. (2014) · doi:10.2217/ebo.13.543
Factors associated with the post-operative recurrence of Crohn's disease
Laffin, M. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3rn30p5r
Omics technologies and the choice of treatment strategy for inflammatory intestinal diseases
Угаров, И. В., Смирнова, О. А., Lychkova, A. E., & Kostyuchenko, L. N. (2018) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro2018703118
Microbiome and Allogeneic Hematopoietic Stem Cell Transplantation
Chilkulwar, A. R., Weber, D., Jenq, R. R., & Holler, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812630-1.00009-8
Use of Probiotics, Prebiotics and Dietary Fibres in Inflammatory Bowel Disease
Silva, M. P. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3125qr85
Premraj, N., Valcheva, R. S., & Dieleman, L. A. (2021) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwab002.228
The Role of High Sugar Diets in Colitis
Rajaruban, S. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-tthe-t208
Biologische Therapie chronisch entzündlicher Darmerkrankungen
Düker, G., & Lentze, M. J. (2007) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-006-1456-7
Young, W. (2011) · Otago University Research Archive (University of Otago)
Nutrition and Hollow Organs of Lower Gastrointestinal Tract
Mutlu, E., Mobarhan, S., & Mutlu, G. M. (2007) · CRC Press eBooks · doi:10.1201/9781420008890.ch61
Guamán, R. M. A. (2015) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.38062
CROHN'S DISEASE: AETIOLOGY, PATHOLOGY, DIAGNOSIS AND MEDICAL TREATMENT
(2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-2723-9.50047-6
Proliferação celular e citocinas BCG especificos em crianças com AIDS
Moreno, Y. M. F. (2007) · doi:10.47749/t/unicamp.2007.411989 · Cited by 1
Probiotic ameliorating effects of altered GABA/glutamate signaling in a rodent model of autismPreprint
Bin-Khattaf, R. M., Alonazi, M. A., Al-Dbass, A. M., Almnaizel, A. T., Aloudah, H. S., Soliman, D. A., & El-Ansary, A. K. (2022) · Research Square · doi:10.21203/rs.3.rs-1518166/v2
Prebiotics, Probiotics, and Dietary Supplements
Dibba, P., Kothari, M., & Grosman, I. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-94953-2_11
Microorganisms in the Pathogenesis and Management of Crohn’s Disease (CD)
Shah, F., & Dwivedi, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-4800-8_13
Kilbaş, E. P. K., & Altındiş, M. (2023) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20239902
A controversial topic: The double edge sword of dietary β-fructans in IBD
Armstrong, H. (2023) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2023.100375
Volkmann, E. R., & McMahan, Z. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_32
Gentili, M., Nunzi, E., Sabbatini, S., Lusenti, E., Cari, L., Mencacci, A., Ballet, N., Migliorati, G., Riccardi, C., Ronchetti, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.18.599634
Strategies for Modulating the Gut Microbiome
Bajwa, S., Shahid, A., Ijaz, L., & Ali, M. A. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_18
Diet-specific impacts on the gut microbiome and their relation to health and inflammation
El-Shafie, S., & Metwaly, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18979-1.00005-8
Imran, M., & Ahmad, B. (2024) · Springer eBooks · doi:10.1007/978-981-97-6948-3_2 · Cited by 1
Nondigestible oligosaccharides
Nie, Q., Zhang, S., & Nie, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21630-5.00002-2
Mendez, H., & Rijkers, G. T. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003191 · Cited by 1
Киселева, Т. Л., Киселева, М. А., & Хлебников, Е. В. (2025) · Традиционная медицина · doi:10.54296/18186173_2025_1_15
Innovations in inulin extraction and production
Akanda, M. K. M., & Mehjabin, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36617-8.00002-2
Derakhshan-sefidi, M., Bakhshi, B., Rasekhi, A., & Saeidnejad, R. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101106
The Role of Prebiotics in Gastrointestinal and Liver Diseases
Hegazi, R. A. F., & Seth, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397154-8.00021-x
Comparative health benefits of inulin and other soluble dietary fibers
Gam, S., Deka, K., Kashyap, B., Ahmed, R., Deka, G., Hazarika, D., Uniyal, P., Pandey, J., Lamichhane, S., & Dutta, K. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36617-8.00019-8
Microbiome-based interventions for irritable bowel syndrome management
Chaudhary, K., Mehra, H., & Dhiman, N. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00048-0
Martínez-Gómez, S., Sousa, J., Cordeiro, A., Barbosa, S. G., Franco‐Duarte, R., Pinheiro, A. C., Rodrigues, L. R., Silvério, S. C., Yáñez, R., & Alonso, J. L. (2026) · Food Research International · doi:10.1016/j.foodres.2026.119754
Update on Diet and Nutritional Therapies in Patients with Inflammatory Bowel Disease
Baniqued, M. R., Shah, N. D., Dominguez, J., & Parian, A. M. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-10049-x · Cited by 1
Chen, A. S.-Y., Nguyen, L. H., Gray, B., Williams, K., Gurung, J., Canha, L. A., McGoldrick, J., Hubbard, J. L., & Khalili, H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1838160
Kucharski, A. A., Brice, C. E., Hayes, N., Duddleston, K. N., & Kurtz, C. C. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1802487
Metadata
- Authors
- Lindsay, J. O.
- Affiliations
- Royal London Hospital (GB)
- Corresponding author
- Lindsay, J O
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2006-03-01
- Volume
- 55
- Issue
- 3
- Pages
- 348-355
- ISSN
- 0017-5749 (ISSN-L)
- PMC
- PMC1856087
- OpenAlex
- W2164571061
- Cited by
- 471
- References
- 55
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 33 · 2023: 19 · 2022: 35 · 2021: 26 · 2020: 32 · 2019: 20 · 2018: 21 · 2017: 18 · 2016: 21 · 2015: 18 · 2014: 26 · 2013: 21 · 2012: 22
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gut (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- fructooligosaccharides, Crohn's disease, Bifidobacterium, dendritic cells, IL-10, TLR2, TLR4, gut microbiota, mucosal immunity, disease activity, prebiotics, rectal mucosa
- MeSH terms
- Adult, Bifidobacterium, Crohn Disease, Dendritic Cells, Feces, Female, Humans, Intestinal Mucosa, Male, Middle Aged, Oligosaccharides, Patient Compliance, Severity of Illness Index, Immunity, Mucosal, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review